Back to search

Total Citations Per Year

Abstract

References (51)

Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production.

1988 • 2,865 citations

Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes.

1989 • 1,989 citations

Nitric oxide. A macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells.

1989 • 1,747 citations

Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells.

1993 • 1,704 citations

Antitumor and antimetastatic activity of interleukin 12 against murine tumors.

1993 • 1,206 citations

Induction of interferon gamma production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers.

1991 • 976 citations

Recombinant IL-12 administration induces tumor regression in association with IFN-gamma production.

1994 • 796 citations

Induction of nitrite/nitrate synthesis in murine macrophages by BCG infection, lymphokines, or interferon-gamma.

1987 • 722 citations

Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis in vivo.

1995 • 710 citations

Biochemical characterization of a gamma interferon-inducible cytokine (IP-10).

1987 • 643 citations

Interleukin‐12 is required for interferon‐γ production and lethality in lipopolysaccharide‐induced shock in mice

1995 • 491 citations

Inhibition of angiogenesis by interleukin-12 is mediated by the interferon-inducible protein 10

1996 • 480 citations

The IP-10 chemokine binds to a specific cell surface heparan sulfate site shared with platelet factor 4 and inhibits endothelial cell proliferation.

1995 • 456 citations

Preferential effect of γ interferon on the synthesis of HLA antigens and their mRNAs in human cells

1982 • 386 citations

Activated murine macrophages induce apoptosis in tumor cells through nitric oxide-dependent or -independent mechanisms.

1994 • 372 citations

Fibroblasts genetically engineered to secrete interleukin 12 can suppress tumor growth and induce antitumor immunity to a murine melanoma in vivo.

1994 • 335 citations

Clinical Trials: IL-12 Deaths: Explanation and a Puzzle

1995 • 333 citations

Regulation of human cytolytic lymphocyte responses by interleukin-12

1992 • 331 citations

Fibroblasts as Efficient Antigen-Presenting Cells in Lymphoid Organs

1995 • 308 citations

Interferon γ-Inducible Protein-10 (IP-10), a Member of the C-X-C Chemokine Family, Is an Inhibitor of Angiogenesis

1995 • 293 citations

Effective eradication of established murine tumors with IL-12 gene therapy using a polycistronic retroviral vector.

1995 • 277 citations

Nitric oxide is an important mediator for tumoricidal activity in vivo.

1994 • 249 citations

Gene gun-mediated skin transfection with interleukin 12 gene results in regression of established primary and metastatic murine tumors.

1996 • 248 citations

Adenovirus-mediated interleukin-12 gene therapy for metastatic colon carcinoma.

1996 • 231 citations

Cancer immunotherapy of established tumors with IL-12. Effective delivery by genetically engineered fibroblasts.

1995 • 206 citations

Systemic administration of rIL-12 induces complete tumor regression and protective immunity: response is correlated with a striking reversal of suppressed IFN-γ production by anti-tumor T cells

1995 • 202 citations

Direct Intratumoral Injection of an Adenovirus Expressing Interleukin-12 Induces Regression and Long-Lasting Immunity That Is Associated with Highly Localized Expression of Interleukin-12

1996 • 193 citations

IL-12 induces T helper 1-directed antitumor response.

1997 • 189 citations

Establishment of a murine model of malignant mesothelioma

1992 • 184 citations

Amount of interleukin 12 available at the tumor site is critical for tumor regression.

1996 • 177 citations

Tumor Antigens are Constitutively Presented in the Draining Lymph Nodes

1999 • 170 citations

A mouse mutant p53 product recognized by CD4+ and CD8+ T cells.

1994 • 168 citations

Cooperation of Natural Killer Cell Stimulatory Factor/Interleukin-12 with Other Stimuli in the Induction of Cytokines and Cytotoxic Cell-Associated Molecules in Human T and NK Cells

1994 • 162 citations

Administration of recombinant interleukin 12 prevents outgrowth of tumor cells metastasizing spontaneously to lung and lymph nodes.

1995 • 138 citations

IL-12 is an effective adjuvant to recombinant vaccinia virus-based tumor vaccines: enhancement by simultaneous B7-1 expression.

1996 • 129 citations

CD4 T cells inhibit in vivo the CD8‐mediated immune response against murine colon carcinoma cells transduced with interleukin‐12 genes

1995 • 125 citations

B7-1 and interleukin 12 synergistically induce effective antitumor immunity.

1995 • 118 citations

Interleukin-12 Promotes the Proliferation and Cytolytic Maturation of Immune Effectors

1993 • 101 citations

Establishment and characterization of five human malignant mesothelioma cell lines derived from pleural effusions

1991 • 99 citations

Effect of Interferon-α2aMalignant Mesothelioma

1993 • 82 citations

High cytokine production and effective antitumor activity of a recombinant vaccinia virus encoding murine interleukin 12.

1995 • 76 citations

Historical perspectives in occupational medicine. Wittenoom, western Australia: A modern industrial disaster

1992 • 65 citations

Patho- and immunobiology of malignant mesothelioma: characterisation of tumour infiltrating leucocytes and cytokine production in a murine model

1994 • 54 citations

Interleukin-12 Induces an Effective Antitumor Response in Malignant Mesothelioma

1998 • 44 citations

Projection of asbestos related diseases in the United States, 1985-2009. I. Cancer.

1988 • 41 citations

Altered CD3 chain and cytokine gene expression in tumor infiltrating T lymphocytes during the development of mesothelioma

1996 • 38 citations

Bone Marrow‐Derived Cells Present MHC Class I‐Restricted Tumour Antigens in Priming of Antitumour Immune Responses

2007 • 34 citations

Transfection of the gene for B7-1 but not B7-2 can induce immunity to murine malignant mesothelioma

1997 • 28 citations

Conventional Treatment and its Effect on Survival of Malignant Pleural Mesothelioma in Western Australia

1982 • 26 citations

Induction and maintenance of T-cell response to a nonimmunogenic murine mesothelioma cell line requires expression of B7-1 and the capacity to upregulate class II major histocompatibility complex expression.

1996 • 17 citations

Projection of Asbestos-related Diseases in the United States, 1985-2009

1989 • 16 citations

Cited By (0)

Loading...
Cytokine Gene Therapy of Mesothelioma (1999) – American Journal of Respiratory Cell and Molecular Biology | Metascience Observatory Explorer